Nature Cancer

ISSN: 2662-1347
Publisher: Springer Nature

Publications (7)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics (2025) Ritter M, Blume C, Tang Y, Patel A, Patel B, Berghaus N, Kada Benotmane J, et al. Journal article Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome (2024) Vinnakota JM, Biavasco F, Schwabenland M, Chhatbar C, Adams RC, Erny D, Duquesne S, et al. Journal article Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (2023) Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, et al. Journal article Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (Nature Cancer, (2023), 4, 9, (1292-1308), 10.1038/s43018-023-00610-2) (2023) Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, et al. Journal article, Erratum Zooming in on dendritic cells for CD40 agonists (2022) Hübner J, Nimmerjahn F Journal article Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas (2021) Friedrich M, Sankowski R, Bunse L, Kilian M, Green E, Ramallo Guevara C, Pusch S, et al. Journal article Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia (2021) Lu J, Cannizzaro E, Meier-Abt F, Scheinost S, Bruch PM, Giles HAR, Lutge A, et al. Journal article